Beauty Farm Medical and Health Industry Inc. (“Beauty Farm”) has called its annual general meeting (AGM) for 26 June 2026 in Hong Kong to seek shareholder approval for a series of corporate actions.

Key AGM Resolutions • Board composition: Five directors—Vice-chairman and CEO Lian Songyong (executive), Li Fangyu (non-executive), Gao Jianming (non-executive), Yi Lin (non-executive) and Liu Teng (independent non-executive)—stand for re-election. • Dividend: A final dividend of HK$0.72 per share for FY 2025, as announced on 27 March 2026, will be put to vote. • Auditor: Re-appointment of PricewaterhouseCoopers for the 2026 financial year; audit fees are estimated at RMB4.38 million. • Share mandates:  – Repurchase Mandate authorising buy-back of up to 10% of issued shares (24.94 million shares based on the current 249.37 million issued shares, excluding 2.23 million treasury shares).  – Issuance Mandate permitting new issues and/or sale of treasury shares up to 20% of issued share capital (49.87 million shares).  – Extension Mandate increasing the issuance limit by the number of shares actually repurchased. • Constitutional update: Adoption of a new amended and restated Memorandum and Articles of Association to align with updated Hong Kong Listing Rules, including provisions for hybrid and electronic meetings.

Key Timetable • Register closure for AGM: 23 – 26 June 2026 (both dates inclusive). • Record date for dividend entitlement: 27 August 2026; register closes 21 – 27 August 2026.

Shareholders of record on 26 June 2026 are entitled to attend and vote. Proxy forms must be lodged with Computershare Hong Kong Investor Services by 9:30 a.m. on 24 June 2026.